var singsData = [{"date":new Date(2012,1,27),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,1,27),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,1,27),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,1,28),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains PCLN to Buy. Target Price is $850; previously $700.","showOnAxis":false},{"date":new Date(2012,1,28),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Evercore Partners maintains PCLN to Equal-Weight. Target Price is $570; previously $540.","showOnAxis":false},{"date":new Date(2012,1,28),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains PCLN to Buy. Target Price is $695; previously $590.","showOnAxis":false},{"date":new Date(2012,1,28),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Keegan maintains PCLN to Outperform. Target Price is $730; previously $625.","showOnAxis":false},{"date":new Date(2012,1,28),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Stanley maintains PCLN to Overweight. Target Price is $725; previously $690.","showOnAxis":false},{"date":new Date(2012,1,28),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"PiperJaffray maintains PCLN to Overweight. Target Price is $727; previously $670.","showOnAxis":false},{"date":new Date(2012,1,28),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains PCLN to Neutral. Target Price is $680; previously $550.","showOnAxis":false},{"date":new Date(2012,10,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,10,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,10,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,10,1),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, PCLN reports 2012 Q3's earning $12.4 per share and revenue $1700MM. This beats analyst's estimated EPS $11.81, beats estimated revenue $1650MM.","showOnAxis":false},{"date":new Date(2012,10,2),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Stifel Nicolaus upgrades PCLN to Buy from Hold. Target Price is $760.","showOnAxis":false},{"date":new Date(2012,10,2),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains PCLN to Outperform. Target Price is $838; previously $806.","showOnAxis":false},{"date":new Date(2012,10,2),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains PCLN to Buy. Target Price is $800; previously $750.","showOnAxis":false},{"date":new Date(2012,10,2),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains PCLN to Buy. Target Price is $780; previously $740.","showOnAxis":false},{"date":new Date(2012,10,20),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JG Capital initiates coverage on PCLN to Overweight. Target Price is $780.","showOnAxis":false},{"date":new Date(2012,10,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,10,8),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2012,10,8),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,11,10),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Deutsche Bank downgrades PCLN to Hold from Buy. Target Price is $710; previously $800.","showOnAxis":false},{"date":new Date(2012,11,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,11,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,11,12),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Janney Capital initiates coverage on PCLN to Neutral. Target Price is $650.","showOnAxis":false},{"date":new Date(2012,11,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,2,16),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Stanley maintains PCLN to Overweight. Target Price is $775; previously $725.","showOnAxis":false},{"date":new Date(2012,2,22),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"PiperJaffray maintains PCLN to Overweight. Target Price is $763; previously $727.","showOnAxis":false},{"date":new Date(2012,2,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2012,2,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,2,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,2,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,2,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,2,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,2,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2012,2,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,2,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,2,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Unregistered Sales of Equity Securities\r\n","showOnAxis":true},{"date":new Date(2012,3,10),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Cowen & Co. initiates coverage on PCLN to Outperform.","showOnAxis":false},{"date":new Date(2012,3,11),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Benchmark maintains PCLN to Buy. Target Price is $840; previously $692.","showOnAxis":false},{"date":new Date(2012,3,11),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs maintains PCLN to Buy. Target Price is $875; previously $700.","showOnAxis":false},{"date":new Date(2012,3,27),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Bank oferica maintains PCLN to Buy. Target Price is $800; previously $740.","showOnAxis":false},{"date":new Date(2012,4,7),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains PCLN to Overweight. Target Price is $810; previously $730.","showOnAxis":false},{"date":new Date(2012,4,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,4,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,4,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,4,9),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, PCLN reports 2012 Q1's earning $3.54 per share and revenue $1037MM..","showOnAxis":false},{"date":new Date(2012,5,6),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains PCLN to Overweight. Target Price is $770; previously $810.","showOnAxis":false},{"date":new Date(2012,5,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2012,6,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains PCLN to Outperform. Target Price is $822; previously $820.","showOnAxis":false},{"date":new Date(2012,6,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,7,17),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,7,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,7,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,7,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,7,7),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"PCLN reports 2012 Q2's earning $7.85 per share and revenue $1330MM. This beats analyst's estimated EPS $7.37, misses estimated revenue $1350MM.","showOnAxis":false},{"date":new Date(2012,7,8),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Bank of America downgrades PCLN to Neutral from Buy. Target Price is $615; previously $790.","showOnAxis":false},{"date":new Date(2012,7,8),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Monness Crespi Hardt downgrades PCLN to Neutral from Buy.","showOnAxis":false},{"date":new Date(2012,7,8),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Stifel Nicolaus downgrades PCLN to Hold from Buy.","showOnAxis":false},{"date":new Date(2012,7,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains PCLN to Overweight. Target Price is $725; previously $800.","showOnAxis":false},{"date":new Date(2012,7,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Benchmark maintains PCLN to Buy. Target Price is $725; previously $840.","showOnAxis":false},{"date":new Date(2012,7,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains PCLN to Buy. Target Price is $740; previously $850.","showOnAxis":false},{"date":new Date(2012,7,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains PCLN to Outperform. Target Price is $727; previously $820.","showOnAxis":false},{"date":new Date(2012,7,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains PCLN to Buy. Target Price is $675; previously $713.","showOnAxis":false},{"date":new Date(2012,7,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs maintains PCLN to Buy. Target Price is $760; previously $860.","showOnAxis":false},{"date":new Date(2012,7,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains PCLN to Overweight. Target Price is $650; previously $770.","showOnAxis":false},{"date":new Date(2012,7,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Stanley maintains PCLN to Overweight. Target Price is $710; previously $780.","showOnAxis":false},{"date":new Date(2012,7,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"PiperJaffray maintains PCLN to Overweight. Target Price is $675; previously $811.","showOnAxis":false},{"date":new Date(2012,7,9),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Lazard downgrades PCLN to Neutral.","showOnAxis":false},{"date":new Date(2012,8,21),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Cantor Fitzgerald initiates coverage on PCLN to Buy. Target Price is $740.","showOnAxis":false},{"date":new Date(2012,8,4),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies assumes PCLN to Buy. Target Price is $740; previously $695.","showOnAxis":false},{"date":new Date(2012,8,7),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Nomura upgrades PCLN to Buy from Neutral. Target Price is $700; previously $740.","showOnAxis":false},{"date":new Date(2012,9,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,9,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,9,17),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains PCLN to Outperform. Target Price is $806; previously $727.","showOnAxis":false},{"date":new Date(2013,0,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Nomura maintains PCLN to Buy. Target Price is $820; previously $730.","showOnAxis":false},{"date":new Date(2013,0,29),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Ascendiant initiates coverage on PCLN to Buy. Target Price is $870.","showOnAxis":false},{"date":new Date(2013,0,3),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Bank of America upgrades PCLN to Buy from Neutral. Target Price is $770; previously $690.","showOnAxis":false},{"date":new Date(2013,0,3),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,0,3),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,0,30),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Ascendiant Capital initiates coverage on PCLN to Buy. Target Price is $870.","showOnAxis":false},{"date":new Date(2013,0,31),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Morgan Stanley downgrades PCLN to Equal-Weight from Overweight. Target Price is $730; previously $750.","showOnAxis":false},{"date":new Date(2013,1,22),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,1,22),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,1,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,1,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2013,1,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,1,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,1,26),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, PCLN reports 2012 Q4's earning $6.77 per share and revenue $1190MM. This beats analyst's estimated EPS $6.54, meets estimated revenue $1190MM.","showOnAxis":false},{"date":new Date(2013,1,27),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Ascendiant Capital maintains PCLN to Buy. Target Price is $875; previously $870.","showOnAxis":false},{"date":new Date(2013,1,27),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Cantor Fitzgerald maintains PCLN to Buy. Target Price is $800; previously $750.","showOnAxis":false},{"date":new Date(2013,1,27),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains PCLN to Outperform. Target Price is $895; previously $847.","showOnAxis":false},{"date":new Date(2013,1,27),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains PCLN to Hold. Target Price is $745; previously $710.","showOnAxis":false},{"date":new Date(2013,1,27),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs maintains PCLN to Buy. Target Price is $825; previously $770.","showOnAxis":false},{"date":new Date(2013,1,27),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains PCLN to Overweight. Target Price is $835; previously $740.","showOnAxis":false},{"date":new Date(2013,1,27),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains PCLN to Buy. Target Price is $820; previously $780.","showOnAxis":false},{"date":new Date(2013,1,27),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"PiperJaffray maintains PCLN to Overweight. Target Price is $800; previously $756.","showOnAxis":false},{"date":new Date(2013,1,27),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus maintains PCLN to Buy. Target Price is $860; previously $760.","showOnAxis":false},{"date":new Date(2013,10,20),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Goldman Sachs upgrades PCLN to Conviction Buy from Buy. Target Price is $1500; previously $1260.","showOnAxis":false},{"date":new Date(2013,10,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2013,10,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,10,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,10,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Unregistered Sales of Equity Securities\r\n","showOnAxis":true},{"date":new Date(2013,10,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Bank of America maintains PCLN to Buy. Target Price is $1220; previously $1060.","showOnAxis":false},{"date":new Date(2013,10,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Stanley maintains PCLN to Overweight. Target Price is $1150.","showOnAxis":false},{"date":new Date(2013,10,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,10,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,10,7),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, PCLN reports 2013 Q3's earning $17.33 per share and revenue $2269MM. This beats analyst's estimated EPS $16.21, beats estimated revenue $2210MM.","showOnAxis":false},{"date":new Date(2013,10,8),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Monness Crespi Hardt upgrades PCLN to Buy from Neutral. Target Price is $1250.","showOnAxis":false},{"date":new Date(2013,10,8),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Monness, Crespi, Hardt upgrades PCLN to Buy from Neutral.","showOnAxis":false},{"date":new Date(2013,10,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Benchmark maintains PCLN to Buy. Target Price is $1200; previously $1100.","showOnAxis":false},{"date":new Date(2013,10,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus maintains PCLN to Buy. Target Price is $1250; previously $1200.","showOnAxis":false},{"date":new Date(2013,11,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,2,1),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Lazard upgrades PCLN to Buy from Neutral.","showOnAxis":false},{"date":new Date(2013,2,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JMP Securities initiates coverage on PCLN to Market Outperform. Target Price is $850.","showOnAxis":false},{"date":new Date(2013,2,21),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Evercore Partners assumes PCLN to Overweight. Target Price is $850.","showOnAxis":false},{"date":new Date(2013,3,2),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS initiates coverage on PCLN to Buy. Target Price is $825.","showOnAxis":false},{"date":new Date(2013,4,20),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Deutsche Bank upgrades PCLN to Buy from Hold. Target Price is $900; previously $715.","showOnAxis":false},{"date":new Date(2013,4,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Completion of Acquisition or Disposition of Assets\r\n","showOnAxis":true},{"date":new Date(2013,4,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,4,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2013,4,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2013,4,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,4,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,4,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2013,4,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Unregistered Sales of Equity Securities\r\n","showOnAxis":true},{"date":new Date(2013,4,29),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Lazard maintains PCLN to Buy. Target Price is $950; previously $859.","showOnAxis":false},{"date":new Date(2013,4,30),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,4,30),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,4,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,4,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,4,9),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, PCLN reports 2013 Q1's earning $5.76 per share and revenue $1300MM. This beats analyst's estimated EPS $5.27, beats estimated revenue $1280MM.","showOnAxis":false},{"date":new Date(2013,5,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,5,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,5,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2013,6,10),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Susquehanna initiates coverage on PCLN to Positive. Target Price is $1080.","showOnAxis":false},{"date":new Date(2013,6,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus maintains PCLN to Buy. Target Price is $1025; previously $860.","showOnAxis":false},{"date":new Date(2013,6,30),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"PiperJaffray maintains PCLN to Overweight. Target Price is $1034; previously $850.","showOnAxis":false},{"date":new Date(2013,6,8),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Morgan Stanley upgrades PCLN to Overweight from Equal-Weight. Target Price is $1010; previously $760.","showOnAxis":false},{"date":new Date(2013,7,1),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Bank of America maintains PCLN to Buy. Target Price is $940; previously $925.","showOnAxis":false},{"date":new Date(2013,7,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Completion of Acquisition or Disposition of Assets\r\n","showOnAxis":true},{"date":new Date(2013,7,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,7,8),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,7,8),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,7,8),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, PCLN reports 2013 Q2's earning $9.7 per share and revenue $1680MM. This beats analyst's estimated EPS $9.38, beats estimated revenue $1660MM.","showOnAxis":false},{"date":new Date(2013,7,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2013,7,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Bank of America maintains PCLN to Buy. Target Price is $1060; previously $940.","showOnAxis":false},{"date":new Date(2013,7,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Benchmark maintains PCLN to Buy. Target Price is $1100; previously $800.","showOnAxis":false},{"date":new Date(2013,7,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Cantor Fitzgerald maintains PCLN to Buy. Target Price is $1050; previously $900.","showOnAxis":false},{"date":new Date(2013,7,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains PCLN to Buy. Target Price is $1120; previously $980.","showOnAxis":false},{"date":new Date(2013,7,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs maintains PCLN to Buy. Target Price is $1200; previously $985.","showOnAxis":false},{"date":new Date(2013,7,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains PCLN to Overweight. Target Price is $1130; previously $1040.","showOnAxis":false},{"date":new Date(2013,7,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains PCLN to Buy. Target Price is $1130; previously $1005.","showOnAxis":false},{"date":new Date(2013,7,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Stanley maintains PCLN to Overweight. Target Price is $1150; previously $1010.","showOnAxis":false},{"date":new Date(2013,7,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"PiperJaffray maintains PCLN to Overweight. Target Price is $1100; previously $1034.","showOnAxis":false},{"date":new Date(2013,7,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus maintains PCLN to Buy. Target Price is $1200; previously $1025.","showOnAxis":false},{"date":new Date(2013,8,12),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Janney Capital initiates coverage on PCLN to Neutral. Target Price is $925.","showOnAxis":false},{"date":new Date(2013,9,21),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Susquehanna maintains PCLN to Positive. Target Price is $1200; previously $1135.","showOnAxis":false},{"date":new Date(2013,9,22),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse assumes PCLN to Outperform. Target Price is $1250.","showOnAxis":false},{"date":new Date(2013,9,23),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"FBR Capital initiates coverage on PCLN to Outperform. Target Price is $1250.","showOnAxis":false},{"date":new Date(2014,0,7),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Stanley maintains PCLN to Overweight. Target Price is $1320; previously $1210.","showOnAxis":false},{"date":new Date(2014,1,13),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains PCLN to Outperform. Target Price is $1450; previously $1275.","showOnAxis":false},{"date":new Date(2014,1,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Monness Crespi Hardt maintains PCLN to Buy. Target Price is $1500; previously $1250.","showOnAxis":false},{"date":new Date(2014,1,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,1,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,1,20),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Oracle Investment Research initiates coverage on PCLN to Strong Buy. Target Price is $1400.","showOnAxis":false},{"date":new Date(2014,1,21),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Bank of America maintains PCLN to Buy. Target Price is $1400; previously $1300.","showOnAxis":false},{"date":new Date(2014,1,21),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Macquarie maintains PCLN to Outperform. Target Price is $1500; previously $1380.","showOnAxis":false},{"date":new Date(2014,1,21),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Stanley maintains PCLN to Overweight. Target Price is $1450; previously $1320.","showOnAxis":false},{"date":new Date(2014,10,14),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Cantor Fitzgerald maintains PCLN to Buy. Target Price is $1350; previously $1500.","showOnAxis":false},{"date":new Date(2014,10,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse assumes PCLN to Outperform. Target Price is $1450.","showOnAxis":false},{"date":new Date(2014,10,25),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,10,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,10,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,10,4),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains PCLN to Outperform. Target Price is $1450; previously $1555.","showOnAxis":false},{"date":new Date(2014,10,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains PCLN to Buy. Target Price is $1410; previously $1460.","showOnAxis":false},{"date":new Date(2014,10,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"FBR Capital maintains PCLN to Outperform. Target Price is $1225; previously $1500.","showOnAxis":false},{"date":new Date(2014,10,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JMP Securities maintains PCLN to Market Outperform. Target Price is $1300; previously $1450.","showOnAxis":false},{"date":new Date(2014,10,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains PCLN to Buy. Target Price is $1500; previously $1545.","showOnAxis":false},{"date":new Date(2014,11,15),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,11,16),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Bank of America maintains PCLN to Buy. Target Price is $1310; previously $1265.","showOnAxis":false},{"date":new Date(2014,11,2),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"FBR Capital downgrades PCLN to Market Perform from Outperform. Target Price is $1225.","showOnAxis":false},{"date":new Date(2014,2,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,2,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,3,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2014,3,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,4,8),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Raymond James upgrades PCLN to Strong Buy from Outperform.","showOnAxis":false},{"date":new Date(2014,4,8),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,4,8),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,4,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains PCLN to Buy. Target Price is $1500; previously $1480.","showOnAxis":false},{"date":new Date(2014,5,12),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2014,5,12),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,5,12),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,5,12),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,5,27),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Buckingham Research initiates coverage on PCLN to Neutral. Target Price is $1400.","showOnAxis":false},{"date":new Date(2014,5,30),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Oppenheimer initiates coverage on PCLN to Outperform. Target Price is $1450.","showOnAxis":false},{"date":new Date(2014,5,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2014,6,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2014,6,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,6,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Completion of Acquisition or Disposition of Assets\r\n","showOnAxis":true},{"date":new Date(2014,6,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,6,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,7,11),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,7,11),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,7,12),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains PCLN to Outperform. Target Price is $1600; previously $1500.","showOnAxis":false},{"date":new Date(2014,7,12),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains PCLN to Buy. Target Price is $1520; previously $1300.","showOnAxis":false},{"date":new Date(2014,7,12),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains PCLN to Buy. Target Price is $1545; previously $1500.","showOnAxis":false},{"date":new Date(2014,7,12),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Macquarie maintains PCLN to Outperform. Target Price is $1595; previously $1500.","showOnAxis":false},{"date":new Date(2014,7,12),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Pacific Crest maintains PCLN to Outperform. Target Price is $1565; previously $1475.","showOnAxis":false},{"date":new Date(2014,7,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,7,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,7,13),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus initiates coverage on PCLN to Buy. Target Price is $1600.","showOnAxis":false},{"date":new Date(2014,7,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2014,7,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,7,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,7,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2014,7,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Unregistered Sales of Equity Securities\r\n","showOnAxis":true},{"date":new Date(2014,7,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,7,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,8,16),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,8,16),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,8,16),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,8,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2014,8,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,8,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2014,8,5),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Evercore Partners downgrades PCLN to Equal-weight from Overweight. Target Price is $1350; previously $1450.","showOnAxis":false},{"date":new Date(2014,9,10),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Evercore Partners downgrades PCLN to Hold from Equal-Weight. Target Price is $1250; previously $1350.","showOnAxis":false},{"date":new Date(2014,9,10),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Susquehanna maintains PCLN to Positive. Target Price is $1475; previously $1500.","showOnAxis":false},{"date":new Date(2014,9,15),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains PCLN to Outperform. Target Price is $1550; previously $1600.","showOnAxis":false},{"date":new Date(2014,9,30),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains PCLN to Buy. Target Price is $1460; previously $1520.","showOnAxis":false},{"date":new Date(2015,0,23),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains PCLN to Buy. Target Price is $1375; previously $1410.","showOnAxis":false},{"date":new Date(2015,0,8),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Stifel Nicolaus downgrades PCLN from Buy.","showOnAxis":false},{"date":new Date(2015,1,18),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JMP Securities maintains PCLN to Market Outperform. Target Price is $1230; previously $1300.","showOnAxis":false},{"date":new Date(2015,1,19),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,1,19),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,1,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"RBC Capital maintains PCLN to Outperform. Target Price is $1450; previously $1300.","showOnAxis":false},{"date":new Date(2015,1,20),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Ascendiant Capital maintains PCLN from Buy. Target Price is $1400; previously $1500.","showOnAxis":false},{"date":new Date(2015,1,20),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains PCLN to Buy. Target Price is $1425; previously $1375.","showOnAxis":false},{"date":new Date(2015,1,20),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains PCLN to Market Outperform. Target Price is $1375; previously $1230.","showOnAxis":false},{"date":new Date(2015,1,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,1,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,1,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,1,25),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,1,25),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,1,26),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Stanley initiates coverage on PCLN to Equal-Weight. Target Price is $1300.","showOnAxis":false},{"date":new Date(2015,10,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2015,10,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,10,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,10,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2015,10,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,10,5),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Deutsche Bank downgrades PCLN to Hold from Buy.","showOnAxis":false},{"date":new Date(2015,10,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,10,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,10,9),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Stifel Nicolaus downgrades PCLN to Hold.","showOnAxis":false},{"date":new Date(2015,11,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,11,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,11,16),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,11,16),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,2,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,2,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,2,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,2,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2015,2,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,2,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2015,2,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2015,2,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,2,18),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains PCLN to Overweight. Target Price is $1352; previously $1375.","showOnAxis":false},{"date":new Date(2015,2,3),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2015,2,3),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,2,3),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2015,2,31),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Stifel Nicolaus upgrades PCLN to Buy from Hold. Target Price is $1400.","showOnAxis":false},{"date":new Date(2015,2,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,2,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,3,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,3,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,3,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,3,6),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Argus Research initiates coverage on PCLN to Buy. Target Price is $1480.","showOnAxis":false},{"date":new Date(2015,4,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Guggenheim initiates coverage on PCLN to Neutral.","showOnAxis":false},{"date":new Date(2015,4,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,4,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,4,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,4,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,5,19),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2015,5,19),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,5,19),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2015,5,19),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Termination of a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2015,5,22),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Deutsche Bank downgrades PCLN to Hold from Buy. Target Price is $1325; previously $1425.","showOnAxis":false},{"date":new Date(2015,5,3),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays initiates coverage on PCLN to Equal-Weight. Target Price is $1200.","showOnAxis":false},{"date":new Date(2015,5,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2015,6,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2015,6,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,7,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,7,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,8,4),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Redburn Partners initiates coverage on PCLN to Buy.","showOnAxis":false},{"date":new Date(2015,8,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,0,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Wells Fargo initiates coverage on PCLN to Market Perform.","showOnAxis":false},{"date":new Date(2016,0,27),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Goldman Sachs downgrades PCLN to Neutral from Buy.","showOnAxis":false},{"date":new Date(2016,0,27),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains PCLN to Hold. Target Price is $1333; previously $1475.","showOnAxis":false},{"date":new Date(2016,0,5),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Raymond James downgrades PCLN to Outperform from Strong Buy.","showOnAxis":false},{"date":new Date(2016,1,17),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,1,17),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,1,17),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, PCLN reports 2015 Q4's earning $12.63 per share and revenue $2000MM. This beats analyst's estimated EPS $11.84, beats estimated revenue $1960MM.","showOnAxis":false},{"date":new Date(2016,1,18),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains PCLN to Hold. Target Price is $1350; previously $1333.","showOnAxis":false},{"date":new Date(2016,1,18),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Oppenheimer maintains PCLN to Outperform. Target Price is $1460; previously $1300.","showOnAxis":false},{"date":new Date(2016,10,10),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Stifel Nicolaus upgrades PCLN to Buy from Hold. Target Price is $1900; previously $1650.","showOnAxis":false},{"date":new Date(2016,10,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,10,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,10,7),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, PCLN reports 2016 Q3's earning $31.18 per share and revenue $3691MM. This beats analyst's estimated EPS $29.51, beats estimated revenue $3620MM.","showOnAxis":false},{"date":new Date(2016,10,8),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Barclays upgrades PCLN to Overweight. Target Price is $1750; previously $1550.","showOnAxis":false},{"date":new Date(2016,10,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Ascendiant Capital maintains PCLN to Buy. Target Price is $1700; previously $1600.","showOnAxis":false},{"date":new Date(2016,10,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Benchmark maintains PCLN to Buy. Target Price is $1800; previously $1600.","showOnAxis":false},{"date":new Date(2016,10,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Cantor Fitzgerald maintains PCLN to Buy. Target Price is $1750; previously $1560.","showOnAxis":false},{"date":new Date(2016,10,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains PCLN to Outperform. Target Price is $1790; previously $1750.","showOnAxis":false},{"date":new Date(2016,10,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs maintains PCLN to Neutral. Target Price is $1600; previously $1400.","showOnAxis":false},{"date":new Date(2016,10,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JMP Securities maintains PCLN to Market Outperform. Target Price is $1776; previously $1560.","showOnAxis":false},{"date":new Date(2016,10,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains PCLN to Buy. Target Price is $1800; previously $1700.","showOnAxis":false},{"date":new Date(2016,10,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Pacific Crest maintains PCLN to Sector Weight.","showOnAxis":false},{"date":new Date(2016,10,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"RBC Capital maintains PCLN to Outperform. Target Price is $1850; previously $1750.","showOnAxis":false},{"date":new Date(2016,10,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains PCLN to Neutral. Target Price is $1600.","showOnAxis":false},{"date":new Date(2016,10,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Wells Fargo maintains PCLN to Market Perform.","showOnAxis":false},{"date":new Date(2016,11,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"CLSA initiates coverage on PCLN to Buy. Target Price is $1900.","showOnAxis":false},{"date":new Date(2016,2,31),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Pacific Crest initiates coverage on PCLN to Sector Weight.","showOnAxis":false},{"date":new Date(2016,2,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,2,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,2,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Moffett Nathanson initiates coverage on PCLN to Buy. Target Price is $1475.","showOnAxis":false},{"date":new Date(2016,3,15),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,3,27),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,3,27),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2016,3,27),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,4,13),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains PCLN to Equal-Weight. Target Price is $1300; previously $1340.","showOnAxis":false},{"date":new Date(2016,4,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2016,4,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,4,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,4,19),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,4,19),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,4,4),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Guggenheim downgrades PCLN to Neutral from Buy.","showOnAxis":false},{"date":new Date(2016,4,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,4,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,4,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Ascendiant Capital maintains PCLN to Buy. Target Price is $1600; previously $1625.","showOnAxis":false},{"date":new Date(2016,4,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Cantor Fitzgerald maintains PCLN to Buy. Target Price is $1525; previously $1550.","showOnAxis":false},{"date":new Date(2016,4,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains PCLN to Outperform. Target Price is $1580; previously $1600.","showOnAxis":false},{"date":new Date(2016,4,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs maintains PCLN to Neutral. Target Price is $1250.","showOnAxis":false},{"date":new Date(2016,4,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JMP Securities maintains PCLN to Market Outperform. Target Price is $1420; previously $1500.","showOnAxis":false},{"date":new Date(2016,4,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains PCLN to Overweight. Target Price is $1510.","showOnAxis":false},{"date":new Date(2016,4,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains PCLN to Buy. Target Price is $1660.","showOnAxis":false},{"date":new Date(2016,4,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Stanley maintains PCLN to Equal-Weight. Target Price is $1330.","showOnAxis":false},{"date":new Date(2016,4,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Oppenheimer maintains PCLN to Outperform. Target Price is $1420; previously $1460.","showOnAxis":false},{"date":new Date(2016,4,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"RBC Capital maintains PCLN to Outperform. Target Price is $1600; previously $1700.","showOnAxis":false},{"date":new Date(2016,5,2),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2016,5,22),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Barclays upgrades PCLN to Overweight from Equal-Weight. Target Price is $1500; previously $1300.","showOnAxis":false},{"date":new Date(2016,5,30),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Morgan Stanley upgrades PCLN to Overweight from Equal-Weight. Target Price is $1525; previously $1330.","showOnAxis":false},{"date":new Date(2016,7,18),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Evercore ISI Group upgrades PCLN to Buy from Hold. Target Price is $1650; previously $1350.","showOnAxis":false},{"date":new Date(2016,7,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2016,7,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,7,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,7,4),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, PCLN reports 2016 Q2's earning $13.93 per share and revenue $2556MM. This beats analyst's estimated EPS $12.69, misses estimated revenue $2580MM.","showOnAxis":false},{"date":new Date(2016,7,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains PCLN to Overweight. Target Price is $1550; previously $1500.","showOnAxis":false},{"date":new Date(2016,7,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains PCLN to Hold. Target Price is $1450; previously $1330.","showOnAxis":false},{"date":new Date(2016,7,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs maintains PCLN to Neutral. Target Price is $1400; previously $1250.","showOnAxis":false},{"date":new Date(2016,7,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains PCLN to Overweight. Target Price is $1620; previously $1460.","showOnAxis":false},{"date":new Date(2016,7,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains PCLN to Buy. Target Price is $1600; previously $1475.","showOnAxis":false},{"date":new Date(2016,8,8),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,9,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,9,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2017,0,10),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup initiates coverage on PCLN to Buy.","showOnAxis":false},{"date":new Date(2017,0,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"MKM Partners initiates coverage on PCLN to Buy. Target Price is $145.","showOnAxis":false},{"date":new Date(2017,0,20),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"MKM Partners initiates coverage on PCLN to Buy. Target Price is $1950.","showOnAxis":false},{"date":new Date(2017,0,4),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Needham initiates coverage on PCLN to Buy. Target Price is $1800.","showOnAxis":false}];